IRIS UniCatt

Bartoccioni, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.203
EU - Europa 2.029
AS - Asia 1.733
SA - Sud America 367
Continente sconosciuto - Info sul continente non disponibili 106
AF - Africa 52
OC - Oceania 6
Totale 7.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.112
SG - Singapore 806
CN - Cina 427
DE - Germania 371
PL - Polonia 341
SE - Svezia 324
IT - Italia 289
BR - Brasile 283
FR - Francia 169
UA - Ucraina 148
VN - Vietnam 131
GB - Regno Unito 99
IE - Irlanda 86
IN - India 71
CA - Canada 52
ID - Indonesia 51
FI - Finlandia 49
BD - Bangladesh 48
JP - Giappone 44
RU - Federazione Russa 42
HK - Hong Kong 31
AR - Argentina 26
TR - Turchia 25
MX - Messico 23
BE - Belgio 21
ES - Italia 20
NL - Olanda 20
IQ - Iraq 19
CO - Colombia 16
EC - Ecuador 14
ZA - Sudafrica 14
AT - Austria 11
CH - Svizzera 11
CI - Costa d'Avorio 11
PK - Pakistan 11
SA - Arabia Saudita 11
VE - Venezuela 10
MA - Marocco 8
UZ - Uzbekistan 8
CL - Cile 6
JO - Giordania 6
AU - Australia 5
IL - Israele 5
IR - Iran 5
NO - Norvegia 5
PY - Paraguay 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LT - Lituania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
CZ - Repubblica Ceca 3
EG - Egitto 3
KG - Kirghizistan 3
MY - Malesia 3
RO - Romania 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
SV - El Salvador 2
AO - Angola 1
BH - Bahrain 1
DM - Dominica 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TO - Tonga 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
Totale 7.393
Salva come PNG Salva come JPEG
Città #
Singapore 464
Ashburn 459
Chandler 394
Warsaw 306
San Jose 214
Jacksonville 98
Beijing 95
New York 91
San Mateo 88
Dublin 84
Los Angeles 79
Ann Arbor 64
Wilmington 61
Woodbridge 60
Cattolica 58
Cambridge 56
Chicago 54
Houston 54
Jakarta 48
Nanjing 48
Bremen 47
Ho Chi Minh City 46
Rome 45
Dearborn 44
Tokyo 42
Lauterbourg 41
Milan 40
North Bergen 36
Boston 35
Fairfield 32
Frankfurt am Main 32
Hanoi 31
Redwood City 28
Santa Clara 28
Seattle 28
Moscow 27
Dallas 26
Hong Kong 25
São Paulo 24
Kraków 23
Lawrence 23
Princeton 23
Marseille 22
Orem 21
Des Moines 20
Hefei 19
Buffalo 18
Denver 18
Atlanta 17
Montreal 17
Nanchang 17
Brussels 16
Munich 16
Brooklyn 15
Düsseldorf 14
Chennai 13
Izmir 13
Paris 13
Washington 13
London 12
Abidjan 11
Columbus 11
San Francisco 11
Baghdad 10
Boardman 10
Helsinki 10
Lancaster 10
Stockholm 10
Amsterdam 9
Council Bluffs 9
Mountain View 9
Norwalk 9
Nürnberg 9
Rio de Janeiro 9
Shenyang 9
Charlotte 8
Hangzhou 8
Hebei 8
Manchester 8
Phoenix 8
Shanghai 8
Tianjin 8
Toronto 8
Turku 8
Zhengzhou 8
Zurich 8
Brasília 7
Changsha 7
Chengdu 7
Johannesburg 7
Philadelphia 7
Quito 7
University Park 7
Amman 6
Baltimore 6
Bexley 6
City of London 6
Dhaka 6
Genoa 6
Haiphong 6
Totale 4.220
Salva come PNG Salva come JPEG
Nome #
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis 344
Age-Related Sarcopenia: Diabetes of the Muscle? 343
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 270
Test domiciliare per la diagnosi integrata di infezione da SARS-CoV-2 243
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 243
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 230
Poly-autoimmunity in patients with myasthenia gravis: A single-center experience 206
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 205
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 204
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 202
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 194
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 187
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 185
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 181
A Genome-wide Association Study of Myasthenia Gravis 181
Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment 177
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 167
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 167
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 164
Myasthenia gravis with antibodies to MuSK: an update 164
Skeletal muscle cells: from local inflammatory response to active immunity 159
Response to therapy in myasthenia gravis with anti-MuSK antibody 159
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis 154
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 154
SNRI effective treatment does not restore changes of immune and inflammatory parameters in depressed patients 151
Anti-AChR-negative myasthenia gravis: clinical and immunological features 146
BAFF serum levels in myasthenia gravis: effects of therapy 144
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 143
Pattern of ocular involvement in myasthenia gravis with MuSK antibodies 140
Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis 138
Overcoming challenges in the diagnosis and treatment of myasthenia gravis 131
Management challenges in muscle-specific tyrosine kinase myasthenia gravis. 128
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 127
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 123
Early-onset myasthenia gravis: clinical characteristics and response to therapy 111
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 106
Myasthenia gravis and associated autoimmune diseases 104
IL-6, monocyte infiltration and parenchymal cells 104
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 101
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 100
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 97
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 88
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 83
Immune-inflammatory response changes in patients with major depressive disorder 83
Why Does an I.M. Immunization Work? 79
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 70
MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies 62
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 54
Totale 7.496
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.038
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022427 0 35 11 20 46 11 12 78 21 26 76 91
2022/20231.083 148 140 66 201 64 121 41 104 124 31 30 13
2023/2024599 16 134 24 43 32 78 37 50 10 20 68 87
2024/2025990 26 54 80 19 77 19 28 68 205 76 180 158
2025/20262.513 338 50 117 367 580 127 385 156 127 130 61 75
2026/2027111 74 37 0 0 0 0 0 0 0 0 0 0
Totale 7.496